drugset / Trial / NCT00700063
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
RandomizedParallel-groupTriple-blindTreatment
Summary
This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.
Timeline
- Start
- 2008-06
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ingenol mebutate | Small molecule | 0.005 % | Topical |
| Subject | ingenol mebutate | Small molecule | 0.01 % | Topical |
| Subject | ingenol mebutate | Small molecule | 0.015 % | Topical |